ArticleESC heart failure2022

The first experience with sodium-glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure.

Anastasia D Egorova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.